1. Extracorporeal membrane oxygenation as a direct bridge to heart transplantation in adults 
Shinichi Fukuhara, MD, Koji Takeda, MD, PhD, Paul A. Kurlansky, MD, Yoshifumi Naka, MD, PhD, Hiroo Takayama, MD, PhD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 155, Issue 4, Pages e6 (April 2018)
DOI: /j.jtcvs
Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Kaplan-Meier curves for 90-day and 3-year posttransplant mortality: patients with extracorporeal membrane oxygenation (ECMO) versus patients with continuous-flow left ventricular assist device (CF-LVAD). A, Before propensity matching. B, After propensity matching.
The Journal of Thoracic and Cardiovascular Surgery  , e6DOI: ( /j.jtcvs )
Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Kaplan-Meier curves for 90-day and 3-year posttransplant mortality among patients with extracorporeal membrane oxygenation (ECMO) stratified by model for end-stage liver disease excluding international normalized ratio (MELD-XI) score (low MELD-XI, <13; intermediate MELD-XI, 13-17; and high MELD-XI, >17).
The Journal of Thoracic and Cardiovascular Surgery  , e6DOI: ( /j.jtcvs )
Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

4. Figure E1
Kaplan-Meier curves for 3-year posttransplant mortality after excluding patients who died or were censored within 90 days. ECMO, Extracorporeal membrane oxygenation; CF-LVAD, continuous-flow left ventricular assist device.
The Journal of Thoracic and Cardiovascular Surgery  , e6DOI: ( /j.jtcvs )
Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

5. Figure E2
Kaplan-Meier curves for 90-day and 3-year posttransplant mortality among the propensity-score matched patients after excluding variables with missing data. ECMO, Extracorporeal membrane oxygenation; CF-LVAD, continuous-flow left ventricular assist device.
The Journal of Thoracic and Cardiovascular Surgery  , e6DOI: ( /j.jtcvs )
Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

6. Figure E3
Kaplan-Meier curves for 90-day and 3-year posttransplant mortality among patients with continuous-flow left ventricular assist device stratified by model for end-stage liver disease excluding international normalized ratio (MELD-XI) score. Low MELD-XI, <13; intermediate MELD-XI, 13-17; high MELD-XI, >17.
The Journal of Thoracic and Cardiovascular Surgery  , e6DOI: ( /j.jtcvs )
Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

7. Kaplan-Meier curves for posttransplant mortality up to 3 years after propensity matching.
The Journal of Thoracic and Cardiovascular Surgery  , e6DOI: ( /j.jtcvs )
Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

8. Video 1
Introduction and brief overview of the present study by 1 of the authors. Video available at:
The Journal of Thoracic and Cardiovascular Surgery  , e6DOI: ( /j.jtcvs )
Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

9. The Journal of Thoracic and Cardiovascular Surgery 2018 155, 1607-1618
The Journal of Thoracic and Cardiovascular Surgery  , e6DOI: ( /j.jtcvs )
Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions